Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmien Hoebeeck

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Journal of Cancer|November 11, 2006
High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumorsJasmien Hoebeeck, Evi Michels, Björn Menten, et al.
BMC Cancer|August 28, 2004
No evidence for involvement of SDHD in neuroblastoma pathogenesisKatleen De Preter, Jo Vandesompele, Jasmien Hoebeeck, et al.
Genome Biology|October 5, 2012
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkersAnneleen Decock, Maté Ongenaert, Jasmien Hoebeeck, et al.
Genes, Chromosomes & Cancer|September 8, 2007
ArrayCGH-based classification of neuroblastoma into genomic subgroupsEvi Michels, Jo Vandesompele, Katleen De Preter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationSara De Brouwer, Katleen De Preter, Candy Kumps, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Journal of Cancer|November 11, 2006
High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumorsJasmien Hoebeeck, Evi Michels, Björn Menten, et al.
BMC Cancer|August 28, 2004
No evidence for involvement of SDHD in neuroblastoma pathogenesisKatleen De Preter, Jo Vandesompele, Jasmien Hoebeeck, et al.
Genome Biology|October 5, 2012
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkersAnneleen Decock, Maté Ongenaert, Jasmien Hoebeeck, et al.
Genes, Chromosomes & Cancer|September 8, 2007
ArrayCGH-based classification of neuroblastoma into genomic subgroupsEvi Michels, Jo Vandesompele, Katleen De Preter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationSara De Brouwer, Katleen De Preter, Candy Kumps, et al.
Pageof 2